Sudesh Rao, Sudesh Rao, Sanjeev D Kulkarni, Vikas Marakini
{"title":"VisionGuard: enhancing diabetic retinopathy detection with hybrid deep learning.","authors":"Sudesh Rao, Sudesh Rao, Sanjeev D Kulkarni, Vikas Marakini","doi":"10.1080/17434440.2025.2486476","DOIUrl":"10.1080/17434440.2025.2486476","url":null,"abstract":"<p><strong>Objectives: </strong>Early detection of diabetic retinopathy (DR) and timely intervention are critical for preventing vision loss. Recently, deep learning techniques have shown promising results in streamlining this process. The objective of this study was to develop a novel method, termed MobileFusionNet, which integrates the strengths of MobileNet and GoogleNet architectures to automate the detection of DR better using mobile devices.</p><p><strong>Methods: </strong>The model is implemented in Python and trained on large-scale datasets of retinal images annotated with DR severity levels. The initial step involves pre-processing the images. Further, an advanced feature extraction technique named Histogram of Oriented Gradients (HOG) is utilized, which helps capture the shape/texture information. Finally, the methodology incorporates Linear Discriminant Analysis (LDA), a technique aimed at reducing the dimensionality of the extracted features.</p><p><strong>Results: </strong>The proposed model displays low inference time and is highly energy efficient. The model exhibits high sensitivity and specificity in detecting DR, with an impressive accuracy of 98.19%.</p><p><strong>Conclusions: </strong>The model with its modular architecture allows easy integration and holds great potential for revolutionizing DR detection by democratizing access to accurate and timely screening, particularly in resource-limited settings.</p>","PeriodicalId":94006,"journal":{"name":"Expert review of medical devices","volume":" ","pages":"497-509"},"PeriodicalIF":0.0,"publicationDate":"2025-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143744596","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Focused ultrasound: focused on tremor.","authors":"Benjamin Davidson, Andres M Lozano","doi":"10.1080/17434440.2025.2489493","DOIUrl":"10.1080/17434440.2025.2489493","url":null,"abstract":"<p><strong>Introduction: </strong>Magnetic resonance-guided focused ultrasound (MRgFUS) has emerged as a leading noninvasive therapy for tremor, offering a precise, lesion-based alternative to deep brain stimulation (DBS) and traditional lesioning techniques. By using phased ultrasound arrays to focus energy at intracranial targets, MRgFUS allows for real-time visualization and monitoring, improving safety and efficacy. Initially developed for essential tremor (ET), MRgFUS-VIM-thalamotomy has gained widespread acceptance and is now a first-line option for tremor-dominant Parkinson's disease (TDPD) and other tremor syndromes.</p><p><strong>Areas covered: </strong>This review discusses the fundamental physics of focused ultrasound, key anatomical targets, and the clinical application of MRgFUS thalamotomy, pallidotomy, and subthalamotomy. Skull density ratio (SDR) and energy efficiency are highlighted as crucial factors affecting treatment outcomes. The evolution of MRgFUS as a bilateral treatment, along with the exploration of novel targets such as the pallidothalamic tract, is examined. Additionally, we discuss advancements in FUS neuromodulation, which could complement lesioning by providing temporary or reversible symptom relief.</p><p><strong>Expert opinion: </strong>MRgFUS is poised to further revolutionize tremor treatment with frameless technology, staged bilateral procedures, and the integration of neuromodulation. Future developments may allow for precise, adaptive therapies that enhance both efficacy and patient experience.</p>","PeriodicalId":94006,"journal":{"name":"Expert review of medical devices","volume":" ","pages":"467-475"},"PeriodicalIF":0.0,"publicationDate":"2025-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143784656","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Mariam Hussain, Mona Jaffar-Karballai, Fatima Kayali, Matti Jubouri, Abedalaziz Omar Surkhi, Mohamad Bashir, Ali Murtada
{"title":"How robotic platforms are revolutionizing colorectal surgery techniques: a comparative review.","authors":"Mariam Hussain, Mona Jaffar-Karballai, Fatima Kayali, Matti Jubouri, Abedalaziz Omar Surkhi, Mohamad Bashir, Ali Murtada","doi":"10.1080/17434440.2025.2486481","DOIUrl":"10.1080/17434440.2025.2486481","url":null,"abstract":"<p><strong>Introduction: </strong>In the last two decades, robotic technology has fundamentally transformed the field of colorectal surgery by providing surgeons with unprecedented levels of precision and control. Nevertheless, robotic surgery presents certain challenges such as prolonged operating times, high costs, limited accessibility, and the necessity for specialized training.</p><p><strong>Areas covered: </strong>This comparative review analyzes the impact of robotic platforms on colorectal surgery and its outcomes, with the expanding market of this technology. The major databases including PubMed, Scopus, and Google Scholars were searched using the key term 'robotic assisted surgery,' 'robotic platforms,' and 'colorectal surgery' to identify relevant articles as of August 2024. The most utilized robotic platforms currently available on the market - Da Vinci, Versius, Senhance, and Revo-I - are compared through their peri- and post-operative outcomes, including operative duration, blood loss, hospitalization period, oncological outcomes, and cost, providing a comprehensive insight into the future of robotic-assisted colorectal surgery.</p><p><strong>Expert opinion: </strong>Robotic surgery significantly improves patient outcomes, including shorter postoperative recovery times and effective cancer resection margins. However, challenges faced with these platforms include longer intraoperative times, arm clashing, the need for bedside assistance, and cost. Nevertheless, with the evolution toward managing more complex rectal cancer cases and more challenging dissection planes, the need for robotic platforms will only grow.</p>","PeriodicalId":94006,"journal":{"name":"Expert review of medical devices","volume":" ","pages":"437-453"},"PeriodicalIF":0.0,"publicationDate":"2025-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143744594","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Assessment of patterns and predictors of medical device-related adverse events among oncology patients: a cross-sectional study at a tertiary care hospital.","authors":"Ashutosh Bhosale, Sarasa Meenakshi, Pavan Kumar Narapaka, Chauhan Richa, V Kalaiselvan, Sameer Dhingra, Nitesh Kumar, Radhakrishnan Rajesh, Krishna Murti","doi":"10.1080/17434440.2025.2486471","DOIUrl":"10.1080/17434440.2025.2486471","url":null,"abstract":"<p><strong>Background: </strong>This study aims to identify patterns and predictors of medical device-related adverse events (MDAEs) among radiotherapy patients. Understanding MDAEs is crucial for optimizing patient safety during radiotherapy.</p><p><strong>Methodology: </strong>An observational study conducted from August to December 2023 involved 139 patients undergoing radiotherapy. Demographics, clinical characteristics, and AE reports were collected from patient datasheets and analyzed using SPSS Version 28.</p><p><strong>Results: </strong>Study findings revealed that patients with head and neck cancer were significantly associated with higher rates of skin (OR: 3.56, CI: 1.59-7.96) and mucous membrane reactions. Specific dose ranges, particularly 800-2800 cGy, also predict mucous membrane reactions (OR: 11.12, CI: 3.42-36.1). Furthermore, smokeless habits significantly influenced both skin (OR: 6.04, CI: 1.99-18.3) and mucous membrane reactions (OR: 8.77, CI: 2.57-29.9). In contrast, head and neck cancer patients had reduced likelihoods of pharynx reactions (OR: 0.37, CI: 0.13-1.00), particularly with doses between 2801 and 4800 cGy (OR: 0.45, CI: 0.96-21.6).</p><p><strong>Conclusion: </strong>This study identified a few significant predictors for the occurrence of various types of MDAEs among patients undergoing radiotherapy. Reporting MDAEs can prevent adverse effects caused by medical devices and enhance radiotherapy safety.</p>","PeriodicalId":94006,"journal":{"name":"Expert review of medical devices","volume":" ","pages":"477-487"},"PeriodicalIF":0.0,"publicationDate":"2025-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143756887","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Colin McCloskey, Yasir Abu-Omar, Julian C Bass, Laura Geer, Kathleen Stoddard, Cory M Alwardt, Lawrence Lambrecht, Bryan A Whitson
{"title":"Device profile of the integrated VitalFlow ECMO system.","authors":"Colin McCloskey, Yasir Abu-Omar, Julian C Bass, Laura Geer, Kathleen Stoddard, Cory M Alwardt, Lawrence Lambrecht, Bryan A Whitson","doi":"10.1080/17434440.2025.2486479","DOIUrl":"10.1080/17434440.2025.2486479","url":null,"abstract":"<p><strong>Introduction: </strong>Extracorporeal membrane oxygenation (ECMO) is a life support system composed of a pump, an oxygenator, hemocompatible component coating, and integrated monitoring. ECMO systems have evolved greatly since the initial intraoperative cardiopulmonary bypass circuits.</p><p><strong>Areas covered: </strong>This device profile describes the VitalFlow ECMO system, which has been cleared for ECMO use in the United States. This integrated system is designed for the care of the ECMO patient in the intensive care unit. This profile reviews design improvements to the centrifugal pump, the blood flow path and monitoring capabilities of the oxygenator, the hemocompatible surface coating, as well as the user-friendly console and the mobility-focused caddy. Capabilities and advantages over older designs are discussed.</p><p><strong>Expert opinion: </strong>All the components in modern ECMO machines (ie, centrifugal pumps, membrane oxygenators, coated blood circuits, integrated hemodynamic monitoring, and control devices) are individually important. The VitaFlow system integrates these components while still maintaining a degree of modularity, allowing for a small, highly human-compatible, highly physiologically supported system that causes minimal blood trauma and facilitates in-hospital transport and early mobilization.</p>","PeriodicalId":94006,"journal":{"name":"Expert review of medical devices","volume":" ","pages":"415-423"},"PeriodicalIF":0.0,"publicationDate":"2025-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143756889","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Antonio Greco, Giacinto Di Leo, Marco Spagnolo, Daniele Giacoppo, Davide Capodanno
{"title":"Expanding indications for drug-coated balloons in coronary artery disease.","authors":"Antonio Greco, Giacinto Di Leo, Marco Spagnolo, Daniele Giacoppo, Davide Capodanno","doi":"10.1080/17434440.2025.2474179","DOIUrl":"10.1080/17434440.2025.2474179","url":null,"abstract":"<p><strong>Introduction: </strong>Despite technical advances in percutaneous coronary intervention (PCI) and new iterations of drug-eluting stents (DES), complications still occur, including stent thrombosis and in-stent restenosis (ISR). Drug-coated balloons (DCBs) provide a promising option for the treatment of coronary lesions - particularly when DES are undesirable or contraindicated - allowing for PCI without the implantation of metallic devices, thus adhering to the 'leave nothing behind' principle.</p><p><strong>Areas covered: </strong>A comprehensive literature search has been performed on PubMed, Web of Science and Cochrane, up to November 2024, with no significant restrictions. This article provides an overview of available DCB and summarizes the evidence supporting their use in different settings, including ISR, small-vessel disease, de novo large-vessel disease, and bifurcations.</p><p><strong>Expert opinion: </strong>Trials of DCB are heterogeneous with respect to population, sample size, follow-up, anatomical pattern, and device used. Furthermore, they usually have limited statistical power for clinical endpoints. Based on current knowledge, DES may be preferrable for DES-ISR, de novo lesions in large vessels and for the treatment of the main branch in true bifurcations, with DCB approved for small-vessel disease and selected ISR lesions. Ongoing trials are expected to provide definitive insights into the efficacy and safety of DCB in different scenarios.</p>","PeriodicalId":94006,"journal":{"name":"Expert review of medical devices","volume":" ","pages":"321-338"},"PeriodicalIF":0.0,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143525572","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Efficacy of LMA gastro airway versus endotracheal tube for therapeutic endoscopic retrograde cholangiopancreatography under general anesthesia: a randomized trial.","authors":"Anju Gupta, Pramod Kumar Garg, Rajeshwari Subramanium, Shalimar Shalimar, Deepak Gunjan, Soumya Jagannath, Karthik V Iyer, Rajeev Kumar Malhotra","doi":"10.1080/17434440.2025.2479805","DOIUrl":"10.1080/17434440.2025.2479805","url":null,"abstract":"<p><strong>Objectives: </strong>LMA Gastro Airway (LGA) is an advanced airway device that allows simultaneous endoscopy and ventilation during endoscopic retrograde cholangiopancreatography (ERCP). It can be an alternative to an endotracheal tube (ETT) and hasten recovery from general anesthesia (GA). We aimed to compare LGA with ETT regarding recovery from anesthesia and adverse respiratory events.</p><p><strong>Methods: </strong>In this randomized controlled trial, 60 adult patients undergoing ERCP under GA were included. The airway was secured with an ETT (Group A, <i>n</i> = 30) or LGA (Group B, <i>n</i> = 30). The primary outcomes were the emergence time and adverse respiratory events.</p><p><strong>Results: </strong>LGA and ETT effectively maintained ventilation with comparable respiratory adverse events. The success rate of insertion of LGA was high (92%), and the insertion time [median (IQR)] of LGA was significantly shorter [37 s (28-56) vs 14.5 s (11-21)] (<i>p</i> < 0.001). The emergence [8(6.0-13.3) vs. 3 (3-5)] and total recovery time [20.5(14.75-30) vs. 12.5 (8.8-19)] was considerably shorter with LMA Gastro, with similar postoperative complications. The endoscopic satisfaction [3 (2-3) vs. 2 (1-3), <i>p</i> < 0.001] was better in the ETT group.</p><p><strong>Conclusion: </strong>LGA provides faster recovery times with a similar safety profile to ETT. It is a suitable alternative to ETT for patients undergoing ERCP.</p><p><strong>Trial registration: </strong>CTRI/2020/08/027268; Principal Investigator: Dr Anju Gupta, Date of registration: 20 August 2020.</p>","PeriodicalId":94006,"journal":{"name":"Expert review of medical devices","volume":" ","pages":"387-395"},"PeriodicalIF":0.0,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143618092","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Chibuikem A Ikwuegbuenyi, Noah Willett, Evan Wang, Sean Inzerillo, Ibrahim Hussain
{"title":"Expandable cage technology in minimally invasive transforaminal interbody fusion: where are we and what does the future hold?","authors":"Chibuikem A Ikwuegbuenyi, Noah Willett, Evan Wang, Sean Inzerillo, Ibrahim Hussain","doi":"10.1080/17434440.2025.2477610","DOIUrl":"10.1080/17434440.2025.2477610","url":null,"abstract":"<p><strong>Introduction: </strong>Expandable cages are designed to address the limitations of static cages in minimally invasive transforaminal lumbar interbody fusion (MI-TLIF). These devices enable collapsed insertion with in-situ expansion, aiming to restore disc height and lordosis, indirect foraminal decompression, and sagittal alignment with reduced neural and tissue trauma. Advancements in bi-dimensional cage expansion, endplate interaction, and innovative materials have been designed in attempt to improve fusion rates and clinicoradiographic outcomes.</p><p><strong>Areas covered: </strong>This review examines the structural design and mechanisms of expandable interbody cages, their clinical outcomes compared to static cages, and their limitations, including subsidence and cost. PubMed, Scopus, and Google Scholar were reviewed for relevant literature published up until November, 2024. We also discuss emerging technologies, such as bi-planar expansion cage technology and patient-specific implants, and their potential to optimize fusion procedures.</p><p><strong>Expert opinion: </strong>Expandable cages offer clear benefits for MI-TLIF, mainly restoring disc height and minimizing insertion-related risks. Innovations like bi-planar and patient-specific designs help address limitations, but cost and long-term outcomes remain concerns. These devices can improve fusion outcomes, especially in degenerative or deformity cases.</p>","PeriodicalId":94006,"journal":{"name":"Expert review of medical devices","volume":" ","pages":"349-360"},"PeriodicalIF":0.0,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143574871","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Anna Flamigni, Marta Paulina Trojniak, Laura Distefano, Laura Mattioni, Domenica Cupo, Monica Zanier, Anna Arbo
{"title":"Hospital medical device quality and safety monitoring using real-world data from Friuli Venezia Giulia regional health coordination agency.","authors":"Anna Flamigni, Marta Paulina Trojniak, Laura Distefano, Laura Mattioni, Domenica Cupo, Monica Zanier, Anna Arbo","doi":"10.1080/17434440.2025.2475242","DOIUrl":"10.1080/17434440.2025.2475242","url":null,"abstract":"<p><strong>Background: </strong>The medical device and in vitro diagnostic industries are evolving with innovative, high-tech devices. New European regulations aim to create a sustainable, innovation-friendly regulatory framework.</p><p><strong>Research design and methods: </strong>This study is a retrospective analysis of complaints and incidents reported to the Regional Health Coordination Agency in 2023 in the Friuli Venezia Giulia region (Northeast Italy), in collaboration with IRCCS Burlo Garofolo. Safety and usability metrics were used to proactively and reactively monitor the quality and safety of hospital medical devices.</p><p><strong>Results: </strong>A total of 132 reports (57 incidents, 75 complaints) involving 101 different medical devices (0.5% of all ARCS devices) were analyzed; 24 reports classified as complaints were actually incidents. Risk class IIA and European Medical Device Nomenclature (EMDN) A devices were the most frequently reported. The analysis highlighted the need for improved compliance with reporting guidelines, proactive post-market surveillance, and enhanced institution-specific training programs to reduce risk and improve device performance.</p><p><strong>Conclusions: </strong>Proactive and reactive surveillance of medical devices in hospitals can be a useful tool to improve the safety and effectiveness of medical devices in real-world settings. Refining local reporting practices and improving user education will ultimately improve patient safety and outcomes, as well as hospital expenditure.</p>","PeriodicalId":94006,"journal":{"name":"Expert review of medical devices","volume":" ","pages":"369-377"},"PeriodicalIF":0.0,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143560381","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Emma Stevenson, Omer Tarik Esengur, Haoyue Zhang, Benjamin D Simon, Stephanie A Harmon, Baris Turkbey
{"title":"An overview of utilizing artificial intelligence in localized prostate cancer imaging.","authors":"Emma Stevenson, Omer Tarik Esengur, Haoyue Zhang, Benjamin D Simon, Stephanie A Harmon, Baris Turkbey","doi":"10.1080/17434440.2025.2477601","DOIUrl":"10.1080/17434440.2025.2477601","url":null,"abstract":"<p><strong>Introduction: </strong>Prostate cancer (PCa) is a leading cause of cancer-related deaths among men, and accurate diagnosis is critical for effective management. Multiparametric MRI (mpMRI) has become an essential tool in PCa diagnosis due to its superior spatial resolution which enables detailed anatomical, functional information and its resultant ability to detect clinically significant PCa. However, challenges such as subjective interpretation methods and high inter-reader variability remain. In recent years, artificial intelligence (AI) has emerged as a promising solution to enhance the diagnostic performance of mpMRI by automating key tasks such as prostate segmentation, lesion detection, classification.</p><p><strong>Areas covered: </strong>This review provides a comprehensive overview of the current AI applications in prostate mpMRI, discussing advancements in automated image analysis and how AI-driven models are developed to improve detection and risk stratification. A literature search was conducted to examine both machine learning and deep learning techniques applied in this field, highlighting key studies and future directions.</p><p><strong>Expert opinion: </strong>While AI models have shown significant promise, their clinical integration remains limited due to the need for larger, multi-institutional validation studies. As AI continues to evolve, multimodal approaches combining imaging with clinical data are likely to play pivotal role in personalized PCa diagnosis, treatment planning.</p>","PeriodicalId":94006,"journal":{"name":"Expert review of medical devices","volume":" ","pages":"293-310"},"PeriodicalIF":0.0,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12038709/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143582419","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}